Clinical Trial Update: Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial results for pembrolizumab in desmoplastic melanoma, evaluating patients whose tumors could be removed by surgery and those whose tumors could not;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Melanoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Desmoplastic Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-04-23